An in vitro system for the production of hepatitis B virus (HBV) particles was established by the transient expression of transfected HBV DNA using a human hepatocellular carcinoma cell, HuH-7, as a recipient. The 3.6-and 2.2-kilobase transcripts observed were similar to those in virus-infected liver cells. Both transcripts revealed the microheterogeneity of their 5' ends. The formation of virusrelated particles subsequent to the RNA transcription was demonstrated. The core particles observed in the cytoplasm and the virus particles secreted in the culture medium contained the replicative intermediates of HBV DNA and banded at densities of 1.35-1.36 g/cm3 and 1.22-1.24 g/cm3, respectively. Furthermore, the in vitro mutagenesis of the template HBV DNA demonstrated that the P gene as well as the C gene products were essential for the production of HBV particles.
Infection of hepatitis B virus (HBV) causes acute and chronic hepatitis. Furthermore, HBV is known to be a major cause of human liver cancer. HBV DNA has the following unique structural characteristics (1) . Two linear DNA strands (plus and minus) form a circular molecule by annealing each cohesive end region. The minus strand is 3.2 kilobases (kb) in size with a protein linked to its 5' end . The plus strand usually shows various degrees of incompleteness. Similar HBV-like animal viruses have been discovered in woodchucks (woodchuck hepatitis virus), ground squirrels (ground squirrel hepatitis virus, GSHV), and ducks (duck hepatitis B virus, DHBV). The replication cycle of the virus was proposed by Summers and Mason based on their observations of the in vivo replication of DHBV (2) . However, the restricted host range of HBV and lack of a cell culture system for virus production have been major problems hindering from understanding of HBV replication and transcription at the molecular level.
In this investigation, an in vitro system for the production of HBV particles was established by the transient expression of transfected HBV DNA, using a human hepatocellular carcinoma cell as a recipient. The RNA transcription of HBV DNA, similar to that in virus infection in vivo, was observed. Furthermore, mutagenesis of the template HBV DNA indicated virus production to be absolutely dependent on the template plasmid and the P gene as well as the C gene products to be essential for the synthesis of HBV DNA.
MATERIALS AND METHODS
Cell Lines and DNAs. HuH-7 (3), huH2-2 (4), and HLEC-1 (5) were derived from human hepatocellular carcinomas. HuH-7 and HLEC-1 were negative for HBV infection and also for the integrated HBV DNA. HepG2 (6) was derived from hepatoblastoma and was negative for HBV integration.
HuL-1 (7) was an established cell line derived from human fetal liver.
Cloned HBV DNA (pHBV1-1) used for the construction of two different plasmids ( Fig. 1 ) and DNA transfection was from the subtype adr virions, whose nucleotide sequence has been published (8 (11) . A 32P-labeled HBV DNA probe was made by nick-translation (12) .
Preparation of Core and Virus Particles. For preparation of core particles, cells were collected 5 days after DNA transfection and suspended in a hypotonic buffer (20 fractions were subjected to CsCl density gradient centrifugation, as described above. The assay for HBV surface antigen (HBsAg) was conducted with the Abbott AUSRIA II kit.
For detection of HBV DNA, an aliquot of each fraction was treated overnight with 1% NaDodSO4 and 2 mg of proteinase K per ml at 370C and then directly subjected to 1% agarose gel electrophoresis. After the Southern transfer of DNA to the nitrocellulose filter (13), the filter was hybridized with a 32P-labeled HBV DNA. S1 Nuclease Mapping. Appropriate restriction fragments, prepared from the cloned HBV DNA (pHBV1-1), were labeled at their 5' ends with [y-32P]ATP and T4 polynucleotide kinase and then digested with a secondary restriction enzyme to obtain the 5' end-labeled probe. S1 nuclease digestion was performed as described (14) . The protected products were subjected to 7 M urea/polyacrylamide gel electrophoresis. The size of each protected product was estimated by a comparison with the sequence ladder of each probe DNA, which was generated by the method of Maxam and Gilbert (15) .
RESULTS
Cell Lines for the Transient Expression System and Specific Transcripts. As for the human liver cells, three hepatocellular carcinoma cell lines and one hepatoblastoma cell line, HuH-7, huH2-2, HLEC-1, and HepG2, respectively, and the human fetal liver cell line HuL-1 were examined. When the plasmid pHBV-dimer was used as a template, the extent of transient expression was assayed by specific RNA transcription of transfected HBV sequences with S1 nuclease mapping. The results indicated only HuH-7 and HepG2 to significantly exhibit the specific transcripts of HBV DNA. The efficiency was higher in HuH-7 than HepG2. In the case of huH2-2, the efficiency was very low. No specific transcription of HBV DNA was observed in other cell lines under the conditions used. These results indicate cell specificity for the transcription of transfected HBV sequences among human liver-derived cell lines. Consequently, the HuH-7 cell line was chosen for the subsequent experiments.
When HuH-7 cells were transfected with pHBV-dimer or pHBV-2, transfer blot hybridization of total RNA revealed the presence of two major transcripts, whose sizes were estimated to be 3.6 kb and 2.2 kb (data not shown). To locate the starting site of each transcript, an S1 nuclease mapping experiment was carried out ( Fig. 2A ). First, a 3.18-kb BamHI/Sac II fragment labeled at the site of BamHI was used as a probe and the product was analyzed by alkaline agarose gel electrophoresis. Two DNA fragments, 2.85 kb and 1.4 kb, were mainly protected by RNA transcripts. When a 2.05-kb Xba I/BamHI fragment was used, 1.65-kb and 0.25-kb fragments were protected. From the data, the major transcription appeared to start at two different loci: one in a cohesive end region and the other just upstream from the pre-S2 region.
To determine the precise locations of both initiation sites, a short DNA probe of a 0.58-kb Bgl II/BamHI fragment or a 0.86-kb Xba IlApa I fragment was prepared and used for S1 nuclease analyses. When a 0.58-kb Bgl II/BamHI fragment covering the cohesive end region of HBV DNA was used, three species of protected DNAs were separated (Fig. 2B,  lanes a and b) . The sizes of these protected strands were determined by a comparison with the sequence ladder of the probe DNA itself. Based on these data, the end of each protected strand is reproducibly located at nucleotides 1657/8, 1664 ± 1, and 1691 ± 1 in the HBV DNA of adr subtype (Fig. 3A) . Thus, 3.6-kb RNA transcripts have microheterogeneity at their 5' ends. The transcription of three RNA species, tentatively designated as RNA3.6-1, RNA3.6-2, and RNA3.6-3, appeared to start in the cohesive end region. The 3' end of 3.6-kb RNA was deduced from the size determined from the electrophoretic mobility of the RNA and the S1 nuclease mapping data of its 5' end. These results are consistent with the idea that the transcription terminates at the downstream of the poly(A) signal (TATAAA from nucleotide 1790), as indicated by others (17) (18) (19) .
When a 0.86-kb Xba I/Apa I fragment containing pre-S1 and pre-S2 regions was used as a probe, three DNA strands were mainly protected by 2.2-kb RNA (Fig. 2B, lanes c and   d) . The end of each strand is located at nucleotides 3063 + 1, 3081/4, and 3094 ± 1, all of which are located just around the first ATG of pre-S2 (Fig. 3B) . The corresponding RNAs were designated as RNA2.2-1, RNA2.2-2, and RNA2. 2-3. Additionally, one protected DNA strand was weakly observed by the transcript from the upstream region ofpre-S1 (Fig. 2B, lane c) . This RNA was designated as RNA2.6, and its start site was located at the downstream of the "TATA" box estimated from the size of the protected DNA strand (Fig. 3B) .
Detection (20) . In addition, a sharp peak of HBcAg/HBeAg was observed for fraction 22, but it was not correlated with the hybridization pattern of HBV DNA. Thus, HBcAg/HBeAg aggregates may also be present in the cytoplasm.
To ascertain the production of virus-like particles, the particulate fraction prepared from the culture medium was subjected to CsCl density gradient centrifugation (Fig. 4B) . After fractionation of the gradient, hybridization of HBV DNA to blotted DNA from the fractions showed the hybridizable DNA to band at a density of 1.22-1.24 g/cm3. The immunological assay of each fraction of HBsAg also indicated association of HBsAg with the DNA band at a density of 1.22-1.24 g/cm3, clearly indicating the presence of virus particles (20) . The major peak of HBsAg was observed at a density of 1.20 g/cm3, which corresponds to that of small HBsAg particles. Fig. 2 ) were electrophoresed in a sequencing gel and the size of each strand was estimated by a comparison with the sequence ladder of the probe DNA strand. The thick bars represent directly repeating sequences. In addition to DR1 and DR2, d2 and d3 were identified in the cohesive end region (8) , and d3', which is almost identical to d3, was found in the upstream region of pre-S2. The solid lines under nucleotides indicate the conserved sequence stretches around the initiation sites of RNA transcription between HBV and GSHV (8, 16 Core and virus particle fractions obtained from each respective peak were examined by electron microscopy (Fig.  4 A and B) , and the diameters were found to be about 27 nm for core particles and about 42 nm for virus particles together with small HBsAg particles. Those observations confirm that DNA-containing core particles are synthesized in the cytoplasm and that virus particles and small HBsAg particles are secreted into the culture medium under the conditions of this transient system.
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Mutagenesis of the Template HBV DNA. To confirm the dependency of virus production on transfected HBV genes, various mutations were introduced into template HBV DNAs and their functions were examined by the production of viral core particles. In this experiment, the second plasmid, pHBV-2, was used as a template and insertion mutagenesis was conducted with an 8-bp linker DNA. This caused frameshift mutations in the coding sequences of HBV DNA (Fig. SA) . The plasmids pHBV-2AP-1 and pHBV-2AP-2 have an 8-bp insertion at the site of Ssp I (nucleotide 2544) and Stu I (nucleotide 988), respectively. The frameshift mutations caused premature termination of the coding frame in the P (possibly reverse transcriptase) gene. In the plasmid pHBV- 2AC, the linker DNA was inserted into the Stu I site (nucleotide 1895) and the coding frame of the HBcAg gene was destroyed. In the plasmid pHBV-2AX or pHBV-2Acoh, the linker DNA became inserted into one of the Dra I sites (nucleotide 1598) on the pHBV-2 DNA. These two mutations were separately located on either side ofpHBV-2 DNA, since the plasmid pHBV-2 has the same cohesive end region at both ends of the insert, as in the case of retroviruses in terminal redundancy. The plasmid pHBV-2AX produced a defective product of an X gene. The mutation of pHBV-2Acoh is located upstream from the initiation site of the 3.6-kb RNA transcript.
Using these mutated plasmids as templates, core particle fractions were analyzed to detect replicative intermediates by Southern blot hybridization and core protein by an immunological assay of HBcAg/HBeAg (Fig. SB) . When pHBV-2AP-1 and pHBV-2AP-2 were used, no hybridization of HBV DNA was observed. The production of HBcAg/HBeAg in both cases continued to occur (data for pHBV-2AP-1 not shown), indicating only core proteins to be synthesized. Thus, the P gene product is essential for HBV DNA synthesis. Transfection of the plasmid pHBV-2AC caused neither production of HBcAg/HBeAg nor hybridization of HBV DNA. The absence of hybridization may be explained by the absence of core proteins to package replicative intermediates. When the two mutant plasmids pHBV-2AP-1 and pHBV-2AC were transfected together, the formation of DNA-containing core particles was recovered, suggesting the complementation of gene products from two mutant plasmids in the transfected cell. However, the possibility of recombination between two transfected DNAs could not be ruled out. Furthermore, the plasmid pHBV-2A&coh remarkably reduced the production of core particles, as compared with intact pHBV-2. On the contrary, a little reduction of HBV DNA synthesis was observed by the plasmid pHBV-2AX. We also constructed similar mutant plasmids, pHBV-dimerAcoh and pHBV-dimerAX, in which the same mutations were introduced into pHBV-dimer DNA. The same results were observed with these mutant plasmids (data not shown). The data suggest that the X gene product is not related to the HBV DNA synthesis itself in this system but probably is related to the early stage of virus infection in vivo. DISCUSSION In the present study, we established an in vitro system for the production of HBV by the transient expression of transfected HBV DNA, where cloned HBV DNA was directly introduced into hepatocytes to overcome the barrier for virus infection to the cultured cells. Among several cell lines examined so far, HuH-7 exhibited the most efficient transcription of HBV DNA, and the subsequent virus production was demonstrated. A possible explanation for these preferential expressions is that certain factors specific for human hepatocytes may be responsible for the efficiency of the specific transcription of HBV DNA, since there was no difference in the efficiency of transformation with pSV2-neo DNA using these cell lines as recipients.
Analysis of the RNA transcription of HBV DNA revealed the presence of three species of 3.6-kb RNA or 2.2-kb RNA transcripts with microheterogeneity at their 5' ends. This microheterogeneity at the 5' end has been observed in GSHV, in which three species of 3.5-kb genomic transcripts and two species of 2.3-kb S gene transcripts were detected (19) . The coding information of each transcript in our system could not be fully determined, but, by the mapping of the 5' ends, it became apparent that RNA3.6-1 and RNA3.6-2 contained the coding frames for precore protein, core protein, and the P gene product. RNA3.6-3 did not code precore protein. It was also found that RNA2.2-1 could code pre-S2 HBsAg and HBsAg, but RNA2.2-2 and RNA2.2-3 only contained the coding frame for HBsAg. The RNA transcription was, therefore, similar to that of in vivo infection (1) .
At the present, we have no clear evidence to specify the pregenome RNA in these three 3.6-kb RNA candidates. However, Seeger et al. (16) have proposed that the shortest among the three genomic GSHV RNA species was likely to be the pregenomic template for DNA synthesis, based on their results of mapping the 3' end of minus strand GSHV DNA at the same location as the 5' end of the shortest RNA. In the case of HBV DNA, Pasek et al. (21) have already demonstrated the location of the 3' end of minus strand HBV DNA at nucleotide 1692 (in the HBV sequences of subtype adr) by molecular cloning. Therefore, RNA3.6-3 is likely the pregenome RNA, since the 5' end of RNA 3.6-3 was located at nucleotide 1691 ± 1.
In the case of GSHV, three 5' ends of 3.5-kb RNA transcripts are distributed over a 30-nucleotide region (19) . Similarly, the 5' ends of 3.6-kb RNA transcripts obtained in the transient expression system were distributed in the region from nucleotide 1655 and 1690. As shown in Fig. 3A , a comparison of nucleotide sequences in these two regions indicated several sequence stretches to be conserved in HBV and GSHV (8, 22) . Since no particular promoter sequence has been assigned so far for the 3.6-kb RNA transcription, these stretches may play an important role in the initiation of the pregenomic RNA transcription. In the region just upstream from the first ATG of pre-S2, some sequence stretches were also conserved (Fig. 3B) . Those stretches contain the region homologous to the sequences responsible for the initiation of late gene transcription in simian virus 40 (17) . In the upstream region of these sequences, no significant homology could be found between HBV and GSHV. The presence of core particles in the cytoplasm and secretion of virus particles into the culture medium were demonstrated in the cell culture system by CsCl density gradient centrifugation and Southern blot hybridization (Fig.  4 A and B) . Virus particles collected from the culture medium were distributed in a rather broader range of the CsCl density than core particles. Consequently, virus particles secreted into the culture medium may be coated with surface protein (HBsAg) to various extents. The infectivity of these secreted virus particles remains for future investigation. The present transient expression system coupled with in vitro mutagenesis of template HBV DNAs should provide additional information on the molecular mechanism of HBV replication in the future.
